Literature DB >> 12679649

Severe hyperphosphatemia resulting from high-dose liposomal amphotericin in a child with leukemia.

Anita Jain1, Lavjay Butani.   

Abstract

Children with acute lymphoblastic leukemia (ALL) are at risk for serious electrolyte abnormalities. The authors report their experience in managing a child with ALL who developed severe hyperphosphatemia as a consequence of a large exogenous load of phosphorus from high-dose liposomal amphotericin B. Health care providers need to recognize this potentially life-threatening complication of liposomal amphotericin B, since early detection and intervention can prevent significant morbidity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12679649     DOI: 10.1097/00043426-200304000-00012

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  3 in total

1.  Hyperphosphatemia in pediatric oncology patients receiving liposomal amphotericin B.

Authors:  Chad A Knoderer; Holly M Knoderer
Journal:  J Pediatr Pharmacol Ther       Date:  2011-04

2.  Case-control study and case series of pseudohyperphosphatemia during exposure to liposomal amphotericin B.

Authors:  Nicole M Bohm; Katherine C Hoover; Amy E Wahlquist; Yusheng Zhu; Juan Carlos Q Velez
Journal:  Antimicrob Agents Chemother       Date:  2015-08-17       Impact factor: 5.191

3.  Pseudohyperphosphatemia associated with high-dose liposomal amphotericin B therapy.

Authors:  Jason W Lane; Nadja N Rehak; Glen L Hortin; Theoklis Zaoutis; Philip R Krause; Thomas J Walsh
Journal:  Clin Chim Acta       Date:  2007-08-30       Impact factor: 3.786

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.